×

Biotech weighs on S&P

1:02 PM ET Fri, 21 March 2014

CNBC's Dominic Chu reports the health care sector is being dragged down by the biotech sector. Congressional Democrats asked biotech company Gilead to provide insight on pricing for its hepatitis C drug Sovaldi.